Invasive aspergillosis before allogeneic hematopoietic stem cell transplantation: 10-year experience at a single transplant center

Biology of Blood and Marrow Transplantation

Volumn 10, Issue 7, 2004, Pages 494-503

  Fukuda, Takahiro ^a   Boeckh, Michael ^a,b   Guthrie, Katherine A ^a,c   Mattson, Debra K ^a   Owens, Stephanie ^b   Wald, Anna ^a,c   Sandmaier, Brenda M ^a,b   Corey, Lawrence ^a,b   Storb, Rainer F ^a,b   Marr, Kieren A ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Allogeneic; Hematopoietic cell transplantation; History; Invasive aspergillosis

Indexed keywords

AMPHOTERICIN; ANTIFUNGAL AGENT; CORTICOSTEROID DERIVATIVE; CYCLOSPORIN; FLUCONAZOLE; GRANULOCYTE COLONY STIMULATING FACTOR; ITRACONAZOLE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; PYRROLE DERIVATIVE;

ADOLESCENT; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ASPERGILLOSIS; CHILD; CONTROLLED STUDY; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOLOGIC DISEASE; HEMATOLOGIC MALIGNANCY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; LUNG COMPLICATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOMES RESEARCH; PROBABILITY; RECURRENT DISEASE; RETROSPECTIVE STUDY; REVIEW; STATISTICAL SIGNIFICANCE; SURVIVAL; WHOLE BODY RADIATION;

EID: 2942693867     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbmt.2004.02.006     Document Type: Article

References (32)

1. Bow E.J. Loewen R. Cheang M.S. Schacter B. Invasive fungal disease in adults undergoing remission-induction therapy for acute myeloid leukemia: the pathogenetic role of the antileukemic regimen Clin Infect Dis. 21 1995 361-369
2. Cordonnier C. Beaune J. Offner F. Marinus A. Ljungman P. Meunier F. Aspergillosis prior to bone marrow transplantation. Infectious Diseases Working Party of the EBMT and the EORTC Invasive Fungal Infections Cooperative Group Bone Marrow Transplant. 16 1995 323-324
3. Offner F. Cordonnier C. Ljungman P. et al. Impact of previous aspergillosis on the outcome of bone marrow transplantation Clin Infect Dis. 26 1998 1098-1103
4. Xun C.Q. McSweeney P.A. Boeckh M. Storb R.F. Broudy V.C. Thompson J.A. Successful nonmyeloablative allogeneic hematopoietic stem cell transplant in an acute leukemia patient with chemotherapy-induced marrow aplasia and progressive pulmonary aspergillosis [letter to editor] Blood. 94 1999 3273-3276
5. Hermann S. Klein S.A. Jacobi V. et al. Older patients with high-risk fungal infections can be successfully allografted using non-myeloablative conditioning in combination with intensified supportive care regimens Br J Haematol. 113 2001 446-454
6. Singhal S. Safdar A. Chiang K.Y. et al. Non-myeloablative allogeneic transplantation ("microallograft") for refractory myeloma after two preceding autografts: feasibility and efficacy in a patient with active aspergillosis Bone Marrow Transplant. 26 2000 1231-1233
7. Bielorai B. Toren A. Wolach B. et al. Successful treatment of invasive aspergillosis in chronic granulomatous disease by granulocyte transfusions followed by peripheral blood stem cell transplantation Bone Marrow Transplant. 26 2000 1025-1028
8. Clarke K. Szer J. Shelton M. Coghlan D. Grigg A. Multiple granulocyte transfusions facilitating successful unrelated bone marrow transplantation in a patient with very severe aplastic anemia complicated by suspected fungal infection Bone Marrow Transplant. 16 1995 723-726
9. Ozsahin H. von Planta M. Muller I. et al. Successful treatment of invasive aspergillosis in chronic granulomatous disease by bone marrow transplantation, granulocyte colony-stimulating factor-mobilized granulocytes, and liposomal amphotericin-B Blood. 92 1998 2719-2724
10. Wong K. Waters C.M. Walesby R.K. Surgical management of invasive pulmonary aspergillosis in immunocompromised patients Eur J Cardiothorac Surg. 6 1992 138-142
11. Lupinetti F.M. Behrendt D.M. Giller R.H. Trigg M.E. de Alarcon P. Pulmonary resection for fungal infection in children undergoing bone marrow transplantation J Thorac Cardiovasc Surg. 104 1992 684-687
12. McWhinney P.H.M. Kibbler C.C. Hamon M.D. et al. Progress in the diagnosis and management of aspergillosis in bone marrow transplantation: 13 years' experience Clin Infect Dis. 17 1993 397-404
13. Reichenberger F. Habicht J. Kaim A. et al. Lung resection for invasive pulmonary aspergillosis in neutropenic patients with hematologic diseases Am J Respir Crit Care Med. 158 1998 885-890
14. Nosari A. Oreste P. Cairoli R. et al. Invasive aspergillosis in haematological malignancies: Clinical findings and management for intensive chemotherapy completion Am J Hematol. 68 2001 231-236
15. Schattenberg A. de Vries F. de Witte T. Cohen O. Donnelly J.P. de Pauw B.E. Allogeneic bone marrow transplantation after partial lobectomy for aspergillosis of the lung Bone Marrow Transplant. 3 1988 509-512
16. Yeghen T. Kibbler C.C. Prentice H.G. et al. Management of invasive pulmonary aspergillosis in hematology patients: a review of 87 consecutive cases at a single institution Clin Infect Dis. 31 2000 859-868
17. McSweeney P.A. Niederwieser D. Shizuru J.A. et al. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects Blood. 97 2001 3390-3400
18. Niederwieser D. Maris M. Shizuru J.A. et al. Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases Blood. 101 2003 1620-1629
19. Storb R. Deeg H.J. Whitehead J. et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia N Engl J Med. 314 1986 729-735
20. Przepiorka D. Weisdorf D. Martin P. et al. Consensus conference on acute GVHD grading Bone Marrow Transplant. 15 1995 825-828
21. Sullivan K.M. Agura E. Anasetti C. et al. Chronic graft-versus-host disease and other late complications of bone marrow transplantation Semin Hematol. 28 1991 250-259
22. Slavin M.A. Osborne B. Adams R. et al. Efficacy and safety of fluconazole for fungal infections after marrow transplant - a prospective, randomized, double-blind study J Infect Dis. 171 1995 1545-1552
23. Marr K.A. Seidel K. Slavin M. et al. Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial Blood. 96 2000 2055-2061
24. Marr K.A. Crippa F. Leisenring W. et al. Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants Blood. 103 2004 1527-1533
25. Boeckh M. Marr K.A. Infection in hematopoietic stem cell transplantation In: Rubin R.H. Young L.S. (Eds.), Clinical Approach to Infection in the Compromised Host 2002 527-571 Kluwer Academic/Plenum New York
26. Ascioglu S. Rex J.H. de Pauw B. et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus Clin Infect Dis. 34 2002 7-14
27. Denning D.W. Therapeutic outcome in invasive aspergillosis [review]. Clin Infect Dis. 23 1996 608-615
28. Paterson D.L. Singh N. Invasive aspergillosis in transplant recipients [review]. Medicine. 78 1999 123-138
29. Wald A. Leisenring W. van Burik J.-A. Bowden R.A. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation J Infect Dis. 175 1997 1459-1466
30. Marr K.A. Carter R.A. Boeckh M. Martin P. Corey L. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors Blood. 100 2002 4358-4366
31. Hubel K. Carter R.A. Liles W.C. et al. Granulocyte transfusion therapy for infections in candidates and recipients of HPC transplantation: a comparative analysis of feasibility and outcome for community donors versus related donors Transfusion. 42 2002 1414-1421
32. Clark J.G. Hansen J.A. Hertz M.I. Parkman R. Jensen L. Peavy H.H. NHLBI workshop summary: idiopathic pneumonia syndrome after bone marrow transplantation [review] Am Rev Respir Dis. 147 1993 1601-1606